Symbol: |
NARG2
|
Description: |
NMDA receptor regulated 2 [Source:HGNC Symbol;Acc:29885]
|
Location: |
Chr15:60711808-60771359[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:216
Gene |
Compound |
Gen_sig |
Exp_pattern |
NARG2 |
NSC 715472 |
0.037 |
Down |
NARG2 |
NSC 715558 |
0.039 |
Down |
NARG2 |
NSC 715584 |
0.001 |
Down |
NARG2 |
NSC 715648 |
0.039 |
Up |
NARG2 |
Phenol, 4-(5,6-dimethyl-1H-benzimidazol-2-yl)- 2,6-bis(1,1-dimethylethyl)- |
0.006 |
Down |
NARG2 |
NSC 717469 |
0.015 |
Up |
NARG2 |
NSC 717471 |
0.013 |
Down |
NARG2 |
NSC 718314 |
0.029 |
Down |
NARG2 |
NSC 718661 |
0.011 |
Up |
NARG2 |
NSC 719735 |
0.039 |
Up |
NARG2 |
Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate~ -3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spiro-1-(4-t-butyl)cyclohexane |
0.011 |
Down |
NARG2 |
NSC 720375 |
0.001 |
Down |
NARG2 |
3'-C-ethinylcytidine |
0.047 |
Down |
NARG2 |
NSC 723548 |
0.028 |
Down |
NARG2 |
(1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]he xadec-9-ene |
0.015 |
Down |
Expression pattern: Sensitivity / Resistance
Total:15 Current:13
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:73
Total:5 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:2
Gene |
Gen_transcript |
miRNA |
miR_location |
NARG2 |
ENST00000261520 |
hsa-mir-181d |
Chr19:13985724-13985746[+] |
NARG2 |
ENST00000261520 |
hsa-mir-183-5p |
Chr7:129414807-129414828[-] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|